JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$4.16B |
| 2 |
Microsoft
MSFT
|
+$2.29B |
| 3 |
Amazon
AMZN
|
+$2B |
| 4 |
UnitedHealth
UNH
|
+$1.76B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.61B |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.58B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$689M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$659M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.03% |
| 2 | Healthcare | 12.52% |
| 3 | Financials | 10.5% |
| 4 | Consumer Discretionary | 7.88% |
| 5 | Industrials | 7.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5101
Navitas Semiconductor
NVTS
$3.57B
| $115K | ﹤0.01% |
+29,913
| New | +$207K |
|
5102
CALL
RTX Corp
RTX
$297B
| $115K | ﹤0.01% |
1,200
-5,000
| -81% | -$481K |
|
5103
Zeta Global
ZETA
$7.44B
| $115K | ﹤0.01% |
25,576
+19,275
| +306% | +$169K |
|
|
VORB
5104
PUT
DELISTED
Virgin Orbit Holdings, Inc. Common Stock
VORB
| $115K | ﹤0.01% |
+30,000
| New | +$149K |
|
5105
DHI Group
DHX
$174M
| $114K | ﹤0.01% |
22,923
-36,641
| -62% | -$218K |
|
5106
Parke Bancorp
PKBK
$413M
| $113K | ﹤0.01% |
5,416
+833
| +18% | +$19.5K |
|
5107
Invesco KBW High Dividend Yield Financial ETF
KBWD
$433M
| $112K | ﹤0.01% |
6,800
-78,368
| -92% | -$1.4M |
|
5108
Superior Group of Companies
SGC
$210M
| $112K | ﹤0.01% |
6,300
+270
| +4% | +$4.64K |
|
5109
Global Water Resources
GWRS
$256M
| $111K | ﹤0.01% |
8,424
-316
| -4% | -$4.56K |
|
5110
Liquidia Corp
LQDA
$6.45B
| $111K | ﹤0.01% |
+25,515
| New | +$132K |
|
5111
Red Violet
RDVT
$1.18B
| $111K | ﹤0.01% |
5,859
+5,066
| +639% | +$125K |
|
|
IVCP
5112
DELISTED
Swiftmerge Acquisition Corp. Class A Ordinary Share
IVCP
| $111K | ﹤0.01% |
+11,300
| New | +$111K |
|
5113
Caesarstone
CSTE
$105M
| $110K | ﹤0.01% |
12,132
-490
| -4% | -$4.69K |
|
5114
Escalade
ESCA
$287M
| $110K | ﹤0.01% |
8,435
-2,870
| -25% | -$37.6K |
|
|
ITIC
5115
Investors Title Co
ITIC
$534M
| $110K | ﹤0.01% |
700
-182
| -21% | -$31.3K |
|
5116
PUT
MGM Resorts International
MGM
$11.1B
| $110K | ﹤0.01% |
3,800
-116,200
| -97% | -$4.17M |
|
5117
Pure Cycle
PCYO
$273M
| $110K | ﹤0.01% |
10,443
+106
| +1% | +$1.15K |
|
|
VZLA
5118
Vizsla Silver
VZLA
$1.31B
| $110K | ﹤0.01% |
107,200
-180,400
| -63% | -$274K |
|
5119
ALX Oncology
ALXO
$268M
| $109K | ﹤0.01% |
13,428
-5,809
| -30% | -$63.3K |
|
5120
NerdWallet
NRDS
$639M
| $109K | ﹤0.01% |
13,697
+8,870
| +184% | +$90.1K |
|
|
NUTX
5121
Nutex Health
NUTX
$1.28B
| $109K | ﹤0.01% |
+224
| New | +$264K |
|
5122
Palladyne AI
PDYN
$310M
| $109K | ﹤0.01% |
6,810
+5,348
| +366% | +$133K |
|
|
FXLV
5123
DELISTED
F45 Training Holdings Inc.
FXLV
| $109K | ﹤0.01% |
27,831
+6,995
| +34% | +$51.2K |
|
|
AKYA
5124
DELISTED
Akoya BioSciences
AKYA
| $108K | ﹤0.01% |
8,431
+2,138
| +34% | +$22.2K |
|
5125
Destination XL Group
DXLG
$33.2M
| $108K | ﹤0.01% |
+31,953
| New | +$144K |
|
Similar funds
JP Morgan Chase's Q2 2022 Portfolio in Review
As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,729 reduced and 610 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
- JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
- JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
- JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
- JP Morgan Chase opened 568 new positions and closed 610 in Q2 2022.
- JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.
Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.